Ascendis Pharma A/S vs Payoneer Global Inc — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Payoneer Global Inc trades at $7.08 (market cap $2.40B). The key difference: Ascendis Pharma A/S is far larger — about 6.9× Payoneer Global Inc's market cap, and Payoneer Global Inc is trading nearer its 52-week high, Ascendis Pharma A/S nearer its low. Which is the better fit depends on your goals.
| ASND | PAYO | |
|---|---|---|
Market Cap | $16.67B | $2.40B |
Sector | Health | Technology |
52-Week High | $277.18 | $7.17 |
52-Week Low | $189.74 | $4.27 |
Enterprise Value | $17.04B | $2.14B |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →